All News

In-hospital pulmonary rehabilitation improves function and symptoms in COPD patients whether they are on triple therapy or not, a new study confirms.

New findings from a national survey shed light on patient attitudes and experiences with arthritis and joint pain.

Data from the pivotal phase 3 FIGARO-DKD cardiovascular outcomes trial with finerenone reaffirms the agent's dual cardiorenal risk reduction benefits in T2D-associated CKD.

Long COVID symptoms are reported by persons who have had only mild disease, who have been vaccinated and boosted, and even those who had asymptomatic infection.

In patients with type 2 diabetes, for every standard deviation increase in cumulative SBP load there was an increase of at least 10% in CV risk, a new study found.

AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

The American Academy of Physical Medicine and Rehabilitation is a leading voice in the campaign for a national plan to address long COVID.

A 5-fold greater risk for all-cause or CVD-related death in persons diagnosed with T2D before age 40 years should be a call to action for enhanced screening, study authors state.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Physical performance scores used as a proxy for function in adults aged >65 years improved CVD risk prediction beyond traditional risk factors, study authors report.

Artificial sweeteners should not be considered a healthy and safe alternative to sugar, caution French investigators.

Abelacimab is a dual-acting, fully human monoclonal antibody that selectively targets both factor XI and factor XIa with high affinity.

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Reducing blood pressure to 140/90 mm Hg or 130/80 mm Hg in high-risk patients proved either cost-saving or cost-effective at 10 years in a simulation study.

Get answers to 7 questions you may have regarding bivalent booster dose vaccination for patients from the US Centers for Disease Control and Prevention.

The Medical Economics® Fall Physician Bootcamp program provides beyond-the-classroom business training for physicians.

US face time with primary care clinicians has decreased by 10% since 2005 along with number of visits. A new study looks closely at trends in the physician-patient encounter.